25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

5JA1 (Sprint Bioscience AB (publ)) Stock Analysis
Buy, Hold or Sell?

Let's analyze Sprint Bioscience AB (publ) together

I guess you are interested in Sprint Bioscience AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Sprint Bioscience AB (publ)’s Financial Insights
  • 📈 Technical Analysis (TA) – Sprint Bioscience AB (publ)’s Price Targets

I'm going to help you getting a better view of Sprint Bioscience AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sprint Bioscience AB (publ)

I send you an email if I find something interesting about Sprint Bioscience AB (publ).

1. Quick Overview

1.1. Quick analysis of Sprint Bioscience AB (publ) (30 sec.)










1.2. What can you expect buying and holding a share of Sprint Bioscience AB (publ)? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.01
Expected worth in 1 year
€-0.01
How sure are you?
27.3%

+ What do you gain per year?

Total Gains per Share
€-0.02
Return On Investment
-43.3%

For what price can you sell your share?

Current Price per Share
€0.05
Expected price per share
€0.0202 - €0.0568
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sprint Bioscience AB (publ) (5 min.)




Live pricePrice per Share (EOD)
€0.05
Intrinsic Value Per Share
€-1.20 - €-1.44
Total Value Per Share
€-1.19 - €-1.42

2.2. Growth of Sprint Bioscience AB (publ) (5 min.)




Is Sprint Bioscience AB (publ) growing?

Current yearPrevious yearGrowGrow %
How rich?$943.1k$2m-$369.9k-22.0%

How much money is Sprint Bioscience AB (publ) making?

Current yearPrevious yearGrowGrow %
Making money-$464.7k-$11.1k-$453.5k-97.6%
Net Profit Margin-28.2%-7,145.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Sprint Bioscience AB (publ) (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#754 / 908

Most Revenue
#442 / 908

Most Profit
#193 / 908

Most Efficient
#450 / 908
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sprint Bioscience AB (publ)?

Welcome investor! Sprint Bioscience AB (publ)'s management wants to use your money to grow the business. In return you get a share of Sprint Bioscience AB (publ).

First you should know what it really means to hold a share of Sprint Bioscience AB (publ). And how you can make/lose money.

Speculation

The Price per Share of Sprint Bioscience AB (publ) is €0.054. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sprint Bioscience AB (publ).
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sprint Bioscience AB (publ), you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.01. Based on the TTM, the Book Value Change Per Share is €-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is €0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sprint Bioscience AB (publ).

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.01-11.2%-0.01-12.1%0.000.1%-0.01-19.4%-0.01-19.8%
Usd Book Value Change Per Share-0.01-11.2%-0.01-12.3%0.00-0.3%0.00-0.2%0.001.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-11.2%-0.01-12.3%0.00-0.3%0.00-0.2%0.001.1%
Usd Price Per Share0.14-0.11-0.10-0.29-0.27-
Price to Earnings Ratio-5.98--4.41--1.21--4.20--3.82-
Price-to-Total Gains Ratio-23.91--17.51--4.82--12.18--12.18-
Price to Book Ratio10.86-5.77-3.61-5.24-4.76-
Price-to-Total Gains Ratio-23.91--17.51--4.82--12.18--12.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.061236
Number of shares16330
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (16330 shares)-108.22-2.04
Gains per Year (16330 shares)-432.88-8.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-433-4430-8-18
20-866-8760-16-26
30-1299-13090-24-34
40-1732-17420-33-42
50-2164-21750-41-50
60-2597-26080-49-58
70-3030-30410-57-66
80-3463-34740-65-74
90-3896-39070-73-82
100-4329-43400-82-90

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%2.020.00.09.1%2.020.00.09.1%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%6.016.00.027.3%6.016.00.027.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.022.00.0%0.00.022.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%6.016.00.027.3%6.016.00.027.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sprint Bioscience AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.005-0.006+10%0.000-98%0.000-98%0.001-1099%
Book Value Per Share--0.0120.021-44%0.025-54%0.033-65%0.034-65%
Current Ratio--1.1361.402-19%1.627-30%2.828-60%2.774-59%
Debt To Asset Ratio--0.7800.657+19%0.598+30%0.515+51%0.494+58%
Debt To Equity Ratio--3.5362.163+63%1.953+81%1.928+83%1.794+97%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--6090220.9514298410.003+42%3649127.205+67%18608461.174-67%18608461.174-67%
Eps---0.005-0.006+9%0.000-14875%-0.009+74%-0.009+77%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--1.0430.737+42%infnan%infnan%infnan%
Free Cash Flow Per Share---0.008-0.008-8%0.006-231%-0.008-3%-0.008-3%
Free Cash Flow To Equity Per Share---0.008-0.008-8%0.006-230%0.002-491%0.002-491%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.437--------
Intrinsic Value_10Y_min---1.200--------
Intrinsic Value_1Y_max---0.040--------
Intrinsic Value_1Y_min---0.039--------
Intrinsic Value_3Y_max---0.199--------
Intrinsic Value_3Y_min---0.188--------
Intrinsic Value_5Y_max---0.454--------
Intrinsic Value_5Y_min---0.414--------
Market Cap3833853.984-136%9030856.0517046481.628+28%5949573.405+52%18345701.286-51%16677910.260-46%
Net Profit Margin---0.259-0.282+9%-71.459+27505%-233.776+90207%-212.693+82063%
Operating Margin----0%-72.1890%-236.1840%-214.8840%
Operating Ratio--1.7231.736-1%80.816-98%288.234-99%262.339-99%
Pb Ratio4.610-136%10.8585.766+88%3.607+201%5.239+107%4.763+128%
Pe Ratio-2.537+58%-5.977-4.412-26%-1.209-80%-4.202-30%-3.820-36%
Price Per Share0.054-136%0.1270.099+28%0.084+52%0.258-51%0.235-46%
Price To Free Cash Flow Ratio-1.604+58%-3.778-3.814+1%-1.720-54%-3.699-2%-3.362-11%
Price To Total Gains Ratio-10.150+58%-23.908-17.508-27%-4.815-80%-12.175-49%-12.175-49%
Quick Ratio----0%0.076-100%0.275-100%0.288-100%
Return On Assets---0.100-0.098-2%-0.125+25%-0.250+149%-0.258+158%
Return On Equity---0.454-0.319-30%-0.719+58%-0.857+89%-0.831+83%
Total Gains Per Share---0.005-0.006+10%0.000-98%0.000-98%0.001-1099%
Usd Book Value--943145.9861682140.333-44%2052069.815-54%2669117.380-65%2716778.655-65%
Usd Book Value Change Per Share---0.006-0.007+10%0.000-98%0.000-98%0.001-1099%
Usd Book Value Per Share--0.0130.024-44%0.029-54%0.038-65%0.038-65%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--6906310.5594874396.943+42%4138110.250+67%21101994.971-67%21101994.971-67%
Usd Eps---0.006-0.007+9%0.000-14875%-0.010+74%-0.011+77%
Usd Free Cash Flow---677759.027-626924.557-8%519203.289-231%-626624.484-8%-569658.622-16%
Usd Free Cash Flow Per Share---0.010-0.009-8%0.007-231%-0.009-3%-0.009-3%
Usd Free Cash Flow To Equity Per Share---0.010-0.009-8%0.007-230%0.002-491%0.002-491%
Usd Market Cap4347590.418-136%10240990.7627990710.166+28%6746816.241+52%20804025.259-51%18912750.235-46%
Usd Price Per Share0.061-136%0.1440.113+28%0.095+52%0.293-51%0.266-46%
Usd Profit---428342.078-464783.196+9%-11189.178-97%-746379.204+74%-762708.931+78%
Usd Revenue--1654675.9871669247.348-1%1283831.026+29%855427.916+93%822279.745+101%
Usd Total Gains Per Share---0.006-0.007+10%0.000-98%0.000-98%0.001-1099%
 EOD+3 -5MRQTTM+16 -18YOY+12 -225Y+11 -2310Y+11 -23

3.3 Fundamental Score

Let's check the fundamental score of Sprint Bioscience AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.537
Price to Book Ratio (EOD)Between0-14.610
Net Profit Margin (MRQ)Greater than0-0.259
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.136
Debt to Asset Ratio (MRQ)Less than10.780
Debt to Equity Ratio (MRQ)Less than13.536
Return on Equity (MRQ)Greater than0.15-0.454
Return on Assets (MRQ)Greater than0.05-0.100
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Sprint Bioscience AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.175
Ma 20Greater thanMa 500.046
Ma 50Greater thanMa 1000.084
Ma 100Greater thanMa 2000.103
OpenGreater thanClose0.039
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Sprint Bioscience AB (publ)

Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; TREX1, a drug candidate for the treatment of immuno-oncology, radiotherapy and chemotherapy in the treatment of cancer. It also develops PETRA01, a drug candidate for the treatment of cancer. In addition, the company focuses on research of products for the treatment of tumor metabolism and nash. Sprint Bioscience AB (publ) was incorporated in 2009 and is based in Huddinge, Sweden.

Fundamental data was last updated by Penke on 2025-04-07 18:09:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sprint Bioscience AB (publ) earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Sprint Bioscience AB (publ) to the Biotechnology industry mean.
  • A Net Profit Margin of -25.9% means that €-0.26 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sprint Bioscience AB (publ):

  • The MRQ is -25.9%. The company is making a huge loss. -2
  • The TTM is -28.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-25.9%TTM-28.2%+2.3%
TTM-28.2%YOY-7,145.9%+7,117.7%
TTM-28.2%5Y-23,377.6%+23,349.4%
5Y-23,377.6%10Y-21,269.3%-2,108.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.9%-99.7%+73.8%
TTM-28.2%-188.1%+159.9%
YOY-7,145.9%-199.6%-6,946.3%
5Y-23,377.6%-357.6%-23,020.0%
10Y-21,269.3%-488.5%-20,780.8%
4.3.1.2. Return on Assets

Shows how efficient Sprint Bioscience AB (publ) is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sprint Bioscience AB (publ) to the Biotechnology industry mean.
  • -10.0% Return on Assets means that Sprint Bioscience AB (publ) generated €-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sprint Bioscience AB (publ):

  • The MRQ is -10.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.0%TTM-9.8%-0.2%
TTM-9.8%YOY-12.5%+2.8%
TTM-9.8%5Y-25.0%+15.2%
5Y-25.0%10Y-25.8%+0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.0%-12.3%+2.3%
TTM-9.8%-12.2%+2.4%
YOY-12.5%-12.0%-0.5%
5Y-25.0%-13.4%-11.6%
10Y-25.8%-15.3%-10.5%
4.3.1.3. Return on Equity

Shows how efficient Sprint Bioscience AB (publ) is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sprint Bioscience AB (publ) to the Biotechnology industry mean.
  • -45.4% Return on Equity means Sprint Bioscience AB (publ) generated €-0.45 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sprint Bioscience AB (publ):

  • The MRQ is -45.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -31.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.4%TTM-31.9%-13.6%
TTM-31.9%YOY-71.9%+40.0%
TTM-31.9%5Y-85.7%+53.8%
5Y-85.7%10Y-83.1%-2.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.4%-16.1%-29.3%
TTM-31.9%-16.2%-15.7%
YOY-71.9%-15.8%-56.1%
5Y-85.7%-19.5%-66.2%
10Y-83.1%-21.7%-61.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sprint Bioscience AB (publ).

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sprint Bioscience AB (publ) is operating .

  • Measures how much profit Sprint Bioscience AB (publ) makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sprint Bioscience AB (publ) to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sprint Bioscience AB (publ):

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-7,218.9%+7,218.9%
TTM-5Y-23,618.4%+23,618.4%
5Y-23,618.4%10Y-21,488.4%-2,130.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--188.3%+188.3%
TTM--291.0%+291.0%
YOY-7,218.9%-214.8%-7,004.1%
5Y-23,618.4%-368.2%-23,250.2%
10Y-21,488.4%-471.9%-21,016.5%
4.3.2.2. Operating Ratio

Measures how efficient Sprint Bioscience AB (publ) is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.72 means that the operating costs are €1.72 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Sprint Bioscience AB (publ):

  • The MRQ is 1.723. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.736. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.723TTM1.736-0.013
TTM1.736YOY80.816-79.080
TTM1.7365Y288.234-286.498
5Y288.23410Y262.339+25.895
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7232.233-0.510
TTM1.7363.152-1.416
YOY80.8163.084+77.732
5Y288.2345.091+283.143
10Y262.3396.520+255.819
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sprint Bioscience AB (publ).

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sprint Bioscience AB (publ) is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.14 means the company has €1.14 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Sprint Bioscience AB (publ):

  • The MRQ is 1.136. The company is just able to pay all its short-term debts.
  • The TTM is 1.402. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.136TTM1.402-0.266
TTM1.402YOY1.627-0.226
TTM1.4025Y2.828-1.426
5Y2.82810Y2.774+0.054
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1363.616-2.480
TTM1.4023.893-2.491
YOY1.6274.280-2.653
5Y2.8285.791-2.963
10Y2.7746.182-3.408
4.4.3.2. Quick Ratio

Measures if Sprint Bioscience AB (publ) is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sprint Bioscience AB (publ) to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off €0.00 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sprint Bioscience AB (publ):

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.076-0.076
TTM-5Y0.275-0.275
5Y0.27510Y0.288-0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.920-2.920
TTM-3.417-3.417
YOY0.0764.170-4.094
5Y0.2755.727-5.452
10Y0.2886.469-6.181
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sprint Bioscience AB (publ).

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sprint Bioscience AB (publ) assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sprint Bioscience AB (publ) to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.78 means that Sprint Bioscience AB (publ) assets are financed with 78.0% credit (debt) and the remaining percentage (100% - 78.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sprint Bioscience AB (publ):

  • The MRQ is 0.780. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.657. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.780TTM0.657+0.123
TTM0.657YOY0.598+0.059
TTM0.6575Y0.515+0.142
5Y0.51510Y0.494+0.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7800.344+0.436
TTM0.6570.344+0.313
YOY0.5980.332+0.266
5Y0.5150.359+0.156
10Y0.4940.384+0.110
4.5.4.2. Debt to Equity Ratio

Measures if Sprint Bioscience AB (publ) is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sprint Bioscience AB (publ) to the Biotechnology industry mean.
  • A Debt to Equity ratio of 353.6% means that company has €3.54 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sprint Bioscience AB (publ):

  • The MRQ is 3.536. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.163. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ3.536TTM2.163+1.373
TTM2.163YOY1.953+0.209
TTM2.1635Y1.928+0.235
5Y1.92810Y1.794+0.134
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5360.407+3.129
TTM2.1630.427+1.736
YOY1.9530.402+1.551
5Y1.9280.448+1.480
10Y1.7940.493+1.301
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Sprint Bioscience AB (publ) generates.

  • Above 15 is considered overpriced but always compare Sprint Bioscience AB (publ) to the Biotechnology industry mean.
  • A PE ratio of -5.98 means the investor is paying €-5.98 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sprint Bioscience AB (publ):

  • The EOD is -2.537. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.977. Based on the earnings, the company is expensive. -2
  • The TTM is -4.412. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.537MRQ-5.977+3.440
MRQ-5.977TTM-4.412-1.565
TTM-4.412YOY-1.209-3.203
TTM-4.4125Y-4.202-0.210
5Y-4.20210Y-3.820-0.382
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.537-1.809-0.728
MRQ-5.977-2.564-3.413
TTM-4.412-3.191-1.221
YOY-1.209-3.323+2.114
5Y-4.202-6.424+2.222
10Y-3.820-7.149+3.329
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sprint Bioscience AB (publ):

  • The EOD is -1.604. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.778. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.814. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.604MRQ-3.778+2.174
MRQ-3.778TTM-3.814+0.036
TTM-3.814YOY-1.720-2.093
TTM-3.8145Y-3.699-0.115
5Y-3.69910Y-3.362-0.336
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.604-2.461+0.857
MRQ-3.778-3.566-0.212
TTM-3.814-3.951+0.137
YOY-1.720-4.482+2.762
5Y-3.699-8.693+4.994
10Y-3.362-9.796+6.434
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sprint Bioscience AB (publ) is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 10.86 means the investor is paying €10.86 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Sprint Bioscience AB (publ):

  • The EOD is 4.610. Based on the equity, the company is fair priced.
  • The MRQ is 10.858. Based on the equity, the company is expensive. -2
  • The TTM is 5.766. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.610MRQ10.858-6.249
MRQ10.858TTM5.766+5.093
TTM5.766YOY3.607+2.158
TTM5.7665Y5.239+0.527
5Y5.23910Y4.763+0.476
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.6101.676+2.934
MRQ10.8582.283+8.575
TTM5.7662.457+3.309
YOY3.6072.507+1.100
5Y5.2393.773+1.466
10Y4.7634.321+0.442
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets42,055
Total Liabilities32,783
Total Stockholder Equity9,272
 As reported
Total Liabilities 32,783
Total Stockholder Equity+ 9,272
Total Assets = 42,055

Assets

Total Assets42,055
Total Current Assets37,243
Long-term Assets4,812
Total Current Assets
Cash And Cash Equivalents 25,056
Total Current Assets  (as reported)37,243
Total Current Assets  (calculated)25,056
+/- 12,187
Long-term Assets
Property Plant Equipment 4,717
Long-term Assets  (as reported)4,812
Long-term Assets  (calculated)4,717
+/- 95

Liabilities & Shareholders' Equity

Total Current Liabilities32,783
Long-term Liabilities0
Total Stockholder Equity9,272
Total Current Liabilities
Accounts payable 5,442
Other Current Liabilities 27,341
Total Current Liabilities  (as reported)32,783
Total Current Liabilities  (calculated)32,783
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)9,272
Total Stockholder Equity (calculated)0
+/- 9,272
Other
Capital Stock6,982
Common Stock Shares Outstanding 69,820
Net Invested Capital 9,272
Net Working Capital 4,460
Property Plant and Equipment Gross 4,717



6.2. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
60,024
19,244
21,063
56,624
45,823
33,399
17,962
19,808
95,403
79,137
63,913
47,702
34,351
37,422
34,130
23,004
63,768
62,377
52,313
48,300
46,025
42,055
42,05546,02548,30052,31362,37763,76823,00434,13037,42234,35147,70263,91379,13795,40319,80817,96233,39945,82356,62421,06319,24460,024
   > Total Current Assets 
19,453
17,379
19,392
11,797
44,530
32,273
16,151
7,884
92,027
75,937
60,885
44,838
31,649
34,882
31,749
20,758
61,617
57,872
47,320
43,652
41,722
37,243
37,24341,72243,65247,32057,87261,61720,75831,74934,88231,64944,83860,88575,93792,0277,88416,15132,27344,53011,79719,39217,37919,453
       Cash And Cash Equivalents 
11,156
8,380
10,162
1,452
35,416
27,075
13,294
4,656
85,708
70,644
56,981
41,441
26,729
29,493
27,243
15,503
55,072
49,934
39,891
36,005
31,719
25,056
25,05631,71936,00539,89149,93455,07215,50327,24329,49326,72941,44156,98170,64485,7084,65613,29427,07535,4161,45210,1628,38011,156
       Net Receivables 
0
6,824
9,230
10,345
9,114
3,284
2,857
3,228
6,319
5,293
3,904
3,397
4,920
5,389
0
5,255
0
802
0
0
0
0
000080205,25505,3894,9203,3973,9045,2936,3193,2282,8573,2849,11410,3459,2306,8240
       Other Current Assets 
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0000000010000000100000
   > Long-term Assets 
40,571
1,865
1,671
44,827
1,292
1,126
1,811
11,924
3,376
3,200
3,028
2,864
2,702
2,540
2,381
2,246
2,151
4,505
4,993
4,648
4,303
4,812
4,8124,3034,6484,9934,5052,1512,2462,3812,5402,7022,8643,0283,2003,37611,9241,8111,1261,29244,8271,6711,86540,571
       Property Plant Equipment 
0
1,569
1,386
1,203
1,028
872
1,568
1,692
3,154
2,989
2,827
2,674
2,522
2,371
2,222
2,098
2,014
4,378
4,877
4,542
4,208
4,717
4,7174,2084,5424,8774,3782,0142,0982,2222,3712,5222,6742,8272,9893,1541,6921,5688721,0281,2031,3861,5690
       Intangible Assets 
38,771
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000038,771
       Other Assets 
0
246
235
43,574
215
204
193
10,182
172
161
151
140
130
119
0
98
0
0
0
0
0
0
00000098011913014015116117210,18219320421543,5742352460
> Total Liabilities 
8,253
8,227
19,804
23,659
22,156
24,255
22,211
8,451
9,910
8,683
7,664
9,360
9,265
9,234
18,226
18,805
30,950
34,603
27,611
29,609
32,542
32,783
32,78332,54229,60927,61134,60330,95018,80518,2269,2349,2659,3607,6648,6839,9108,45122,21124,25522,15623,65919,8048,2278,253
   > Total Current Liabilities 
8,253
8,227
19,804
23,659
22,155
24,255
22,211
8,451
9,910
8,683
7,664
9,360
9,265
9,234
18,226
18,805
30,950
34,603
27,611
29,609
32,542
32,783
32,78332,54229,60927,61134,60330,95018,80518,2269,2349,2659,3607,6648,6839,9108,45122,21124,25522,15523,65919,8048,2278,253
       Short Long Term Debt 
0
0
0
0
0
10,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000010,00000000
       Accounts payable 
3,402
2,594
3,239
2,130
2,430
3,397
2,435
3,633
3,954
2,923
2,334
2,163
4,219
3,725
2,335
2,430
5,109
5,705
5,956
6,346
6,057
5,442
5,4426,0576,3465,9565,7055,1092,4302,3353,7254,2192,1632,3342,9233,9543,6332,4353,3972,4302,1303,2392,5943,402
       Other Current Liabilities 
4,851
397
16,565
21,529
19,725
2,359
19,776
4,818
5,956
1,220
5,330
7,197
5,046
1,075
15,891
16,375
25,841
13,208
21,655
23,263
26,485
27,341
27,34126,48523,26321,65513,20825,84116,37515,8911,0755,0467,1975,3301,2205,9564,81819,7762,35919,72521,52916,5653974,851
   > Long-term Liabilities 
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000010000
       Other Liabilities 
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000010000
> Total Stockholder Equity
51,771
11,017
1,259
32,965
23,667
9,144
-4,249
11,357
85,493
70,454
56,249
38,342
25,086
28,188
15,904
4,199
32,818
27,774
24,702
18,691
13,483
9,272
9,27213,48318,69124,70227,77432,8184,19915,90428,18825,08638,34256,24970,45485,49311,357-4,2499,14423,66732,9651,25911,01751,771
   Common Stock
0
1,234
1,234
1,234
2,121
2,121
2,125
2,531
3,984
3,984
3,984
3,984
3,984
6,980
0
6,982
0
0
0
0
0
0
0000006,98206,9803,9843,9843,9843,9843,9842,5312,1252,1212,1211,2341,2341,2340
   Retained Earnings Total Equity0000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
882
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000882000



6.3. Balance Sheets

Currency in SEK. All numbers in thousands.




6.4. Cash Flows

Currency in SEK. All numbers in thousands.




6.5. Income Statements

Currency in SEK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue65,641
Cost of Revenue-28,337
Gross Profit37,30437,304
 
Operating Income (+$)
Gross Profit37,304
Operating Expense-85,309
Operating Income-19,668-48,005
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense85,3090
 
Net Interest Income (+$)
Interest Income1,431
Interest Expense-40
Other Finance Cost-0
Net Interest Income1,391
 
Pretax Income (+$)
Operating Income-19,668
Net Interest Income1,391
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-18,277-19,668
EBIT - interestExpense = -40
-18,277
-18,237
Interest Expense40
Earnings Before Interest and Taxes (EBIT)--18,237
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-18,277
Tax Provision-0
Net Income From Continuing Ops-18,277-18,277
Net Income-18,277
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--1,391
 

Technical Analysis of Sprint Bioscience AB (publ)
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sprint Bioscience AB (publ). The general trend of Sprint Bioscience AB (publ) is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sprint Bioscience AB (publ)'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Sprint Bioscience AB (publ) Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sprint Bioscience AB (publ).

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0418 < 0.0512 < 0.0568.

The bearish price targets are: 0.0499 > 0.0202.

Know someone who trades $5JA1? Share this with them.👇

Sprint Bioscience AB (publ) Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sprint Bioscience AB (publ). The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sprint Bioscience AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sprint Bioscience AB (publ). The current macd is -0.01183495.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sprint Bioscience AB (publ) price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sprint Bioscience AB (publ). This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sprint Bioscience AB (publ) price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sprint Bioscience AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartSprint Bioscience AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sprint Bioscience AB (publ). The current adx is 8.42328979.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sprint Bioscience AB (publ) shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Sprint Bioscience AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sprint Bioscience AB (publ). The current sar is 0.06138216.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sprint Bioscience AB (publ) Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sprint Bioscience AB (publ). The current rsi is 47.18. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Sprint Bioscience AB (publ) Daily Relative Strength Index (RSI) ChartSprint Bioscience AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sprint Bioscience AB (publ). The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sprint Bioscience AB (publ) price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sprint Bioscience AB (publ) Daily Stochastic Oscillator ChartSprint Bioscience AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sprint Bioscience AB (publ). The current cci is 78.53.

Sprint Bioscience AB (publ) Daily Commodity Channel Index (CCI) ChartSprint Bioscience AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sprint Bioscience AB (publ). The current cmo is 10.14.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sprint Bioscience AB (publ) Daily Chande Momentum Oscillator (CMO) ChartSprint Bioscience AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sprint Bioscience AB (publ). The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sprint Bioscience AB (publ) Daily Williams %R ChartSprint Bioscience AB (publ) Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sprint Bioscience AB (publ).

Sprint Bioscience AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sprint Bioscience AB (publ). The current atr is 0.00706867.

Sprint Bioscience AB (publ) Daily Average True Range (ATR) ChartSprint Bioscience AB (publ) Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sprint Bioscience AB (publ). The current obv is 63,636.

Sprint Bioscience AB (publ) Daily On-Balance Volume (OBV) ChartSprint Bioscience AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sprint Bioscience AB (publ). The current mfi is 45.54.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Sprint Bioscience AB (publ) Daily Money Flow Index (MFI) ChartSprint Bioscience AB (publ) Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sprint Bioscience AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-28 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-02 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-03 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-09 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-02 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-03 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-09 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-13 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-20 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-24 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-31 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-10 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-20 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-21 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-17 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-19 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-07 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-08 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-15 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Sprint Bioscience AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sprint Bioscience AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.175
Ma 20Greater thanMa 500.046
Ma 50Greater thanMa 1000.084
Ma 100Greater thanMa 2000.103
OpenGreater thanClose0.039
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sprint Bioscience AB (publ) with someone you think should read this too:
  • Are you bullish or bearish on Sprint Bioscience AB (publ)? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sprint Bioscience AB (publ)? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sprint Bioscience AB (publ)

I send you an email if I find something interesting about Sprint Bioscience AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about Sprint Bioscience AB (publ).

Receive notifications about Sprint Bioscience AB (publ) in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.